Psyence Biomedical (Psyence Biomedical) Change In Inventory : $0.00 Mil (TTM As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Change In Inventory?

Psyence Biomedical's change in inventory for the quarter that ended in Mar. 2023 was $0.00 Mil. It means Psyence Biomedical's inventory stayed the same from Mar. 2022 to Mar. 2023 .

Psyence Biomedical's change in inventory for the fiscal year that ended in Mar. 2023 was $0.00 Mil. It means Psyence Biomedical's inventory stayed the same from Mar. 2022 to Mar. 2023 .

Psyence Biomedical's Total Inventories for the quarter that ended in Mar. 2023 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Psyence Biomedical Change In Inventory Historical Data

The historical data trend for Psyence Biomedical's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Change In Inventory Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Change In Inventory

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Change In Inventory	-	-	-

Psyence Biomedical Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Psyence Biomedical (NAS:PBM) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Psyence Biomedical's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Psyence Biomedical's Inventory Turnover for the quarter that ended in Mar. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Psyence Biomedical's Inventory to Revenue for the quarter that ended in Mar. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Psyence Biomedical Change In Inventory Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024